The Effects of Arolycoricidine and Narciprimine on Tumor Cell Killing and Topoisomerase Activity

Records of Natural Products

Volumn 6, Issue 4, 2012, Pages 381-385

  Sarikaya, Buket Bozkurt ^a   Zencir, Sevil ^a   Somer, Nehir Unver ^a   Kaya, Gulen Irem ^a   Onur, Mustafa Ali ^a   Bastida, Jaume ^b   Berenyi, Agnes ^c   Zupko, Istvan ^c   Topcu, Zeki ^a  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Arolycoricidine; Cytostaticity; Dna topoisomerases; Galanthus rizehensis; Narciprimine

Indexed keywords

ANTINEOPLASTIC AGENT; AROLYCORICIDINE; CISPLATIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); NARCIPRIMINE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CELL KILLING; CYTOSTASIS; DOSE RESPONSE; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; GALANTHUS; GALANTHUS RIZEHENSIS; HUMAN; HUMAN CELL; SKIN CARCINOMA; TREATMENT RESPONSE; TUMOR CELL; UTERINE CERVIX CARCINOMA;

EID: 84865396582     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. J. Bastida, R. Lavilla and F. Viladomat (2006). Chemical and Biological Aspects of Narcissus Alkaloids, In: The Alkaloids, ed: Cordell GA, ol. 63, Elsevier, Amsterdam, p. 87.
2. A. Kornienko and A. Evidente (2008). Chemistry, biology and medicinal potential of narciclasine and its congeners, Chem. Rev. 108, 1982-2014.
3. J. C. Wang (1996): DNA topoisomerases, Ann Rev Biochem. 65, 635-692.
4. S. Alpan, S. Gunes and Z. Topcu (2007). 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors, Acta Biochim Pol. 54, 561-565.
5. Z. Topcu, B. Ozturk, O. Kucukoglu and E. Kilic (2008). Inhibition of mammalian type I DNA topoisomerase by Helichrysum pamphylicum is correlated with the total antioxidant capacities of its individual flavonoids, Z Naturforsch C. 63, 69-74.
6. G. Coban, S. Zencir, I. Zupkó, B. Réthy, H. S. Gunes and Z. Topcu (2009). Synthesis and biological activity evaluation of 1H-Benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays, Eur. J. Med. Chem. 44, 2280-2285.
7. F. Piozzi, C. Fuganti, R. Mondelli and G. Ceriotti (1968). Narciclasine and narciprimine, Tetrahedron. 24, 1119-1131.
8. S. Takagi and M. Yamaki (1974). On the constituents of the bulbs of Lycoris sanguinea Maxim, Yakugaku Zasshi. 94, 617-622.
9. W. Zhang, Y. Shen, Q. Shi, C. Zhang, J. Su, H. Li, R. Li and X. Xu (2008). Natural alkaloids contaning lycorenan-7 one, narciprimine and arolycoricidine with antitumor effect, Faming Zhuanli Gongkai Shuomingshu. p. 9.
10. J. Nio, G. M. Hincapié, Y. M. Correa and O. M. Mosquera (2007). Alkaloids of Crinum x powelii "Album" (Amaryllidaceae) and their topoisomerase inhibitory activity, Z. Naturforsch C. 62, 223-226.
11. Z. Topcu and K. L. B. Borden (2000). The yeast two-hybrid system and its pharmaceutical significance, Pharm Res. 17, 1049-1055.
12. A. M. Sobhani, S. A. Ebrahimi and M. Mahmoudian (2002). An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its -carboline alkaloids, J. Pharm. Pharmaceut Sci. 5, 19-23.
13. J. C. Marini, K. G. Miller and P. T. Englund (1980). Decatenation of kinetoplast DNA by topoisomerases, J. Biol. Chem. 255, 4976-4979.
14. Z. Topcu and F. J. Castora (1995). Mammalian mitochondrial DNA topoisomerase I preferentially relaxes supercoils in plasmids containing specific mitochondrial DNA sequences, Biochim Biophys Acta. 1264, 377-387.
15. T. Mosmann (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods. 65, 55-63.